Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Etanercept
Enbrel
Not routinely available
SMC (842/13)
29/03/2023
Indication
For the treatment of polyarthritis (rheumatoid factor positive or negative) and extended oligoarthritis in children and adolescents
Therapeutic Area
Musculoskeletal and joint diseases
Status Description
Not routinely available as local clinical experts do not wish to add the medicine to the formulary at this time or there is a local preference for alternative medicines
Formulation
10mg and 25mg powder and solvent for solution for injection for paediatric use, 25mg and 50mg solution for injection in pre-filled syringe, 50mg solution for injection in pre-filled pen
Comments
-
Link to Advice
Advice Published
11/02/2013
SMC Submission Type
Abbreviated
SMC Status
Restricted